Perivascular Adipocytes in Vascular Disease.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 13 9 2019
medline: 9 4 2020
entrez: 13 9 2019
Statut: ppublish

Résumé

Perivascular adipocytes residing in the vascular adventitia are recognized as distinct endocrine cells capable of responding to inflammatory stimuli and communicating with the sympathetic nervous system and adjacent blood vessel cells, thereby releasing adipocytokines and other signaling mediators to maintain vascular homeostasis. Perivascular adipocytes exhibit phenotypic heterogeneity (both white and brown adipocytes) and become dysfunctional in conditions, such as diet-induced obesity, thus promoting vascular inflammation, vasoconstriction, and smooth muscle cell proliferation to potentially contribute to the development of vascular diseases, such as atherosclerosis, hypertension, and aortic aneurysms. Although accumulating data have advanced our understanding of the role of perivascular adipocytes in modulating vascular function, their impact on vascular disease, particularly in humans, remains to be fully defined. This brief review will discuss the mechanisms whereby perivascular adipocytes regulate vascular disease, with a particular emphasis on recent findings and current limitations in the field of research.

Identifiants

pubmed: 31510794
doi: 10.1161/ATVBAHA.119.312304
pmc: PMC6812617
mid: NIHMS1538437
doi:

Substances chimiques

Adipokines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2220-2227

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL130301
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL126949
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142097
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR070029
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134354
Pays : United States

Références

Circ Res. 2009 Feb 27;104(4):541-9
pubmed: 19122178
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1631-6
pubmed: 24925977
Br J Pharmacol. 2017 Oct;174(20):3496-3513
pubmed: 28063251
Adipocyte. 2019 Dec;8(1):229-239
pubmed: 31250691
Cardiovasc Drugs Ther. 2018 Oct;32(5):503-510
pubmed: 30097828
PLoS One. 2015 May 28;10(5):e0124031
pubmed: 26020520
Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):188-199
pubmed: 30567483
Biol Cell. 2011 Sep;103(9):435-47
pubmed: 21679159
Cardiovasc Drugs Ther. 2018 Oct;32(5):511-518
pubmed: 30073586
Am J Clin Nutr. 2009 Jan;89(1):27-36
pubmed: 19056585
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1621-30
pubmed: 24833795
Lancet. 2018 Sep 15;392(10151):929-939
pubmed: 30170852
Cardiovasc Drugs Ther. 2018 Oct;32(5):531-539
pubmed: 30022354
J Endocrinol. 2008 Apr;197(1):55-64
pubmed: 18372232
Aging Cell. 2019 Aug;18(4):e12969
pubmed: 31087498
Circulation. 2012 Aug 28;126(9):1067-78
pubmed: 22855570
Adipocyte. 2018;7(3):156-165
pubmed: 29956579
Obesity (Silver Spring). 2013 Jul;21(7):1496-503
pubmed: 23754461
Hypertension. 2012 Jan;59(1):158-66
pubmed: 22083158
J Hypertens. 2006 May;24(5):789-801
pubmed: 16612235
Br J Pharmacol. 2018 Sep;175(18):3685-3698
pubmed: 29980164
Cardiovasc Res. 2017 Jul 1;113(8):962-972
pubmed: 28371926
Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E298-307
pubmed: 16985259
Biochem Biophys Res Commun. 2004 Feb 6;314(2):415-9
pubmed: 14733921
Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1180-1193
pubmed: 28473444
Front Physiol. 2018 Feb 06;9:70
pubmed: 29467675
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1723-30
pubmed: 24947528
Cardiovasc Drugs Ther. 2019 Apr;33(2):245-259
pubmed: 30747398
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1629-1644
pubmed: 31189430
Pharmacol Ther. 2014 Jul;143(1):61-73
pubmed: 24560685
Diabetes. 2013 Jun;62(6):1783-90
pubmed: 23704519
Physiol Genomics. 2013 Aug 15;45(16):697-709
pubmed: 23737535
J Cancer. 2016 Nov 26;7(15):2346-2359
pubmed: 27994674
J Am Heart Assoc. 2014 Mar 04;3(2):e000582
pubmed: 24595191
Am J Physiol Heart Circ Physiol. 2015 Jun 1;308(11):H1382-90
pubmed: 25840831
Front Physiol. 2017 Nov 28;8:969
pubmed: 29234289
J Exp Med. 2007 Oct 1;204(10):2449-60
pubmed: 17875676
Horm Mol Biol Clin Investig. 2015 Feb;21(2):137-47
pubmed: 25719334
Diabetes. 2018 Aug;67(8):1549-1560
pubmed: 29794241
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):880-891
pubmed: 29496660
Hypertension. 2008 Jun;51(6):1651-7
pubmed: 18426996
Hypertension. 2017 Oct;70(4):780-789
pubmed: 28760942
Atherosclerosis. 2011 Nov;219(1):33-9
pubmed: 21835408
J Am Coll Cardiol. 2018 Jan 30;71(4):414-425
pubmed: 29389358
Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1425-37
pubmed: 21765057
N Engl J Med. 2009 Apr 9;360(15):1509-17
pubmed: 19357406
Sci Transl Med. 2017 Jul 12;9(398):
pubmed: 28701474
Circulation. 2007 Feb 27;115(8):1029-38
pubmed: 17296858
Hypertension. 2007 Feb;49(2):365-72
pubmed: 17200435
Br J Pharmacol. 2017 Oct;174(20):3466-3481
pubmed: 28147449

Auteurs

Ha Won Kim (HW)

From the Department of Medicine, Vascular Biology Center, Medical College of Georgia at Augusta University.

Eric J Belin de Chantemèle (EJ)

From the Department of Medicine, Vascular Biology Center, Medical College of Georgia at Augusta University.

Neal L Weintraub (NL)

From the Department of Medicine, Vascular Biology Center, Medical College of Georgia at Augusta University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH